Overview

Nebulized Albuterol for Congestive Heart Failure Exacerbation

Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a randomized trial of the use of Albuterol in the setting of acute decompensated Congestive Heart Failure with radiographic evidence of Cardiogenic Pulmonary Edema.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of California, San Francisco
Treatments:
Albuterol